Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines

Volaluck Supajatura, Hiroko Ushio, Akihiro Wada, Kinnosuke Yahiro, Ko Okumura, Hideoki Ogawa, Toshiya Hirayama and Chisei Ra
J Immunol March 15, 2002, 168 (6) 2603-2607; DOI: https://doi.org/10.4049/jimmunol.168.6.2603
Volaluck Supajatura
*Dermatology,
‡Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan; Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroko Ushio
‡Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan; Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akihiro Wada
§Bacteriology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kinnosuke Yahiro
§Bacteriology and
∥Department of Applied Chemistry, Faculty of Engineering, Nagasaki University, Nagasaki, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ko Okumura
†Immunology, and
‡Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan; Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideoki Ogawa
*Dermatology,
‡Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan; Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiya Hirayama
§Bacteriology and
¶Biochemistry, Institute of Tropical Medicine, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chisei Ra
#Department of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Mucosal mast cells strategically located at the optimal site interact with invading bacteria. Presence of VacA, the virulent Helicobacter pylori cytotoxin, is correlated with the severity of H. pylori-induced gastritis. To examine the mechanisms of inflammation in H. pylori-induced gastritis, we administered VacA to the mice. Inoculation of VacA resulted in epithelium vacuolization and marked infiltrations of mast cells and mononuclear cells into the mucosal epithelium within 24 h. In an in vitro study using bone marrow-derived mast cells, VacA directly bound and showed a chemotactic activity to the mast cell. In addition, VacA induced bone marrow-derived mast cells to produce proinflammatory cytokines, TNF-α, macrophage-inflammatory protein-1α, IL-1β, IL-6, IL-10, and IL-13 in a dose-dependent manner without causing degranulation. The present study suggests that early activation of mast cells by VacA may be the host early response to clear the bacteria and also may contribute to the pathogenesis of H. pylori-induced gastritis.

Helicobacter pylori infection is a worldwide problem, and it is now widely accepted that it is one cause of gastric inflammation. The ongoing state of infection might eventually result in the development of atrophic changes and carcinoma (1). VacA, the virulent cytotoxin of H. pylori, has been found mainly in the gastric mucosa and its ability to cause vacuolization has been widely documented in many cell types. The similar vacuoles have also been observed in the gastric epithelia of patients with active chronic gastritis associated with H. pylori infection (2, 3), and the colonization of those strains expressing higher levels of toxin is correlated with the severity of the gastritis lesion, indicating that this toxin plays significant roles in the pathogenesis of H. pylori-induced gastritis (4, 5, 6). Oral treatment of mice with either crude extracts of H. pylori or the purified cytotoxin induces gastric injury that resembles the pathology observed in humans (7, 8). Not only cells of the specific immune system, but also the cells of the innate system such as mast cells, monocytes, and neutrophils are involved in the ongoing state of inflammatory response against this bacterium (9, 10, 11).

Mast cells are known as the main effector cells in IgE-mediated allergic responses, but they also play important roles in innate immune responses against bacteria by releasing cytokines and by recruitment of polymorphonuclear leukocytes (12, 13). Although several lines of evidence support the hypothesis that mast cells participate in the gastric inflammation in H. pylori-infected peptic ulcer (9), it remained to be clarified the exact mechanisms of mast cell activation at the site of H. pylori infection.

In this study, we demonstrated that oral treatment of mice with VacA caused acute inflammation of gastric mucosa with mast cell accumulation. Moreover, we demonstrated direct activation of mast cells by VacA in vitro by showing the chemotactic activity, cytokine production through the binding of VacA to mast cells. Thus, this study has explored the role of this virulence factor in the activation of mast cells, which might be the initial host response to H. pylori infection, and discussed the possible involvement of mast cell activation by VacA in the pathogenesis of H. pylori-induced gastritis.

Materials and Methods

Animals

BALB/c, C3H/HeN, and C3H/HeJ mice were purchased from Japan SLC (Hamamatsu, Japan). All animal experiments were performed under approved manual of the Institutional Review Board of Juntendo University (Tokyo, Japan).

Preparation of purified VacA and Ab to VacA

The purified VacA from toxin-producing strain H. pylori (ATCC 49503; American Type Culture Collection, Manassas, VA) and polyclonal Ab to VacA (14) were kindly provided by Dr. K. Yahiro and Dr. A. Wada (Nagasaki University, Nagasaki, Japan). The preparation of VacA was done as previously described (14). In vitro vacuolating activity of VacA was tested using rapid neutral red uptake assay (15). Because acidic treatment was associated with activation and increased binding of VacA to the receptor of susceptible cells (16), for in vitro experiment VacA was activated by bringing the pH to 1.5 with 1 N HCl for 10 min, and then neutralized to pH 7 with 1 N NaOH.

In vivo administration of VacA to mice

Six-week-old BALB/c mice were deprived of food, but allowed free access to water. After 24 h, the mice received oral administration of saline (0.3 ml) or 20 μg of purified VacA in saline. BSA was used as a high protein control. The administration was repeated after 24 h. After a further 24 or 72 h, the mice were killed and the stomach was excised. The frozen sections were stained by H&E or Alcian blue-Safranin for histological evaluation.

Generation of bone marrow-derived mast cells (BMMCs)3

BMMCs were generated from the femoral bone marrow of mice and maintained in the completed medium in the presence of 10% PWM-stimulated spleen-conditioned medium as a source of mast cell growth factors, as previously described (13). After 4 wk of culture, >99% of cells were identifiable as mast cells as determined by toluidine blue staining and flow cytometric analysis of cell surface expression of c-kit and FcεRI.

Flow cytometric analysis of VacA binding to mast cells

BMMCs (1 × 106 cells/ml) were incubated with 10 μg/ml of activated VacA in balanced salt solution containing 2% BSA for 30 min on ice. After the cells were washed with balanced salt solution twice, the cells were incubated with 1 μg/ml of rabbit anti-VacA Ab, and then with 1 μg/ml of FITC-conjugated goat anti-rabbit IgG (Wako Pure Chemical, Osaka, Japan). The 2.4G2 (BD PharMingen, San Diego, CA) was used as IgG receptor-blocking Ab. The stained cells were analyzed by FACSCaliber (BD Immunocytometry Systems, Mountain View, CA).

Chemotaxis assay of mast cells

Chemotaxis assay of BMMCs was performed as previously described with slight modifications using membrane (5 μM pore size; NeuroProbe, Gaithersburg, MD) coated with human fibronectin (17). VacA in RPMI 1640 containing 0.5% BSA was added into the lower chamber (25 μl). A total of 50 μl of BMMCs (4 × 106 cells/ml) in the same medium were loaded in the upper chamber, and then incubated for 4 h at 37°C. The number of cells adherent to the underside of the filter was counted after staining the membrane with DiffQuick (Kokusai Shiyaku, Kobe, Japan). Stem cell factor (SCF) was used as a positive control.

Measurement of cytokine production from BMMCs

BMMCs (1 × 106 cell/ml) in complete cultured media were stimulated with the indicated concentration of purified VacA at 37°C. According to the preliminary study, the optimal time for stimulation of BMMCs by VacA was 3 h for TNF-α and 6 h for IL-1β, IL-6, IL-10, IL-13, and macrophage-inflammatory protein-1α. The levels of each cytokine in the culture supernatants were determined by ELISA according to the manufacturer’s instructions (Genzyme Techne, Minneapolis, MN).

Statistical analysis

Statistical analysis of data was performed using the Student t test.

Results and Discussion

In vivo effects of oral administration of VacA

Oral administration of VacA in mice caused several aspects of the histological lesions in epithelium of gastric mucosa, namely loss of gastric gland architecture including epithelial vacuolization, edema, erosion, necrosis, and exfoliation 24 h after inoculation (Fig. 1⇓B). The marked infiltrations of mast cells and mononuclear cells and a few eosinophils were observed 24 h after inoculation (Fig. 1⇓, D and F). The mast cells located in the mucosal layer had spindle shape and less granules (Fig. 1⇓, G and H). In contrast, the epithelium of gastric mucosa in control mice 24 h after inoculation of saline did not show any lesion, with rare mucosal mast cells (MMC) and no inflammatory cells (Fig. 1⇓, A, C, and E). Administration of BSA as a high protein control did not show any epithelial lesions nor histological changes, as were seen in VacA-treated mice (data not shown). These pathological changes were not observed 72 h after inoculation of VacA with no mononuclear cell and less mast cell infiltrations (data not shown). Interestingly, there was no significant neutrophil infiltration in the epithelium during the course of experiment. This result was consistent with the report that VacA itself did not cause accumulation of neutrophils (7). In the more controlled mouse model infected with H. pylori, the first signs of gastric inflammation with mononuclear cell infiltration occurred 3 wk after inoculation (4, 18). It is likely that bacteria should colonize and multiply before the onset of disease, and that simultaneously the VacA is gradually accumulated to the levels which are enough for the development of the mucosal damage as observed in this study. In humans, H. pylori infection produces a predominant infiltration of polymorphonuclear leukocytes, little evidence of mast cell infiltration, and usually no evidence of epithelial vacuolization. The differences between this animal model and human H. pylori infection may be partly explained by the fact that we were observing very acute changes occurring within hours of exposure to the toxin and not to whole bacteria, which has more various effects on immune cells. Because H. pylori infection in humans is a slow progression and the gastric disease becomes manifest after prolonged infection, the early inflammatory changes are difficult to recognize. Also, the production of neutralizing Abs to the 87-kDa protein (VacA) in sera of H. pylori-infected patients (2) may help to neutralize the toxin; and therefore, remove its effects of the chronic infection on gastric mucosa. Thus, this model may be relevant to know some aspects of the immune responses in initial acute phase of H. pylori infection.

           FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

VacA causes cell vacuolization and damage to the gastric mucosa with infiltration of mast cells. Gastric tissues of BALB/c mice obtained 24 h after the second inoculation of VacA or saline were stained with H&E (A and B, ×200, and C and D, ×400) or Alcian blue/Safranin (E and F, ×100; G, ×400; and H, ×1000). Epithelium of the gastric mucosa of control mouse treated with saline was normal with no evidence of inflammation (A and C) or mast cell infiltration (E), whereas that of VacA-treated mouse showed evidence of various epithelial damages including marked vacuolization, edema, necrosis, intercellular mononuclear cell infiltration (B and D), and mast cell infiltration (F–H). Sections shown were representative of five mice in a control and VacA-treated group with similar results.

VacA is a chemoattractant for mast cells

Using BMMCs, we next investigated whether the effects of VacA on the accumulation of MMC in epithelium were a direct effect of VacA to the mast cell. As shown in Fig. 2⇓A, BMMCs showed a migratory response to VacA in a dose-dependent manner. Compared with the potent-positive control, SCF, the chemotactic activity of VacA was weaker. This effect of VacA was specific, because the treatment of neutralizing polyclonal Ab to VacA abolished the migratory responses induced by VacA (Fig. 2⇓B). To determine whether the migratory responses induced by VacA were due to directional (chemotaxis) or random (chemokinesis) activation of mast cells, we performed checkerboard analysis. As shown in Table I⇓, in addition to the gradient-dependent migration of BMMCs to various concentrations of VacA in upper and lower wells, increasing concentrations of VacA in the upper wells led to slight dose-dependent migration of mast cells to the lower wells, suggesting that VacA has predominant chemotaxis activity and slight chemokinesis activity. Thus, the accumulation of mast cells in vivo after administration of VacA seems to be a direct effect of VacA to the mast cells. Nevertheless, we cannot exclude the possibility that there are indirect effects of VacA on MMC in vivo via the activation of cells located in the gastric epithelium. Although we do not know where so many mast cells migrated from to the epithelium within a day, the vacuolization and disruption of gastric epithelial cell by VacA may increase the penetration of VacA and the chance to interact with mast cells in the lamina propria.

           FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

VacA stimulates mast cell chemotaxis in vitro. BALB/c BMMCs were used in microchemotaxis assays. A, VacA at indicated concentrations was added to the lower chambers of the 48-well chemotaxis chamber, and incubated for 4 h. SCF was used as positive control. B, VacA (20 μg/ml) stimulated chemotaxis of BMMCs was blocked by indicated concentrations of anti-VacA polyclonal Ab. The total number of migratory cells in the five high power fields was counted. Data shown was the mean ± SD of three independent experiments. ∗∗, p < 0.01, significantly different from the mean value of the corresponding control.

View this table:
  • View inline
  • View popup
Table I.

Checkerboard analysis of the number of migrating mast cells in response to VacAa

VacA directly binds to BMMCs

Because BMMCs did show migratory responses to VacA, we also determined whether VacA could directly bind to the BMMCs. As shown in Fig. 3⇓, immunofluorescence FACS analysis demonstrated that VacA could bind directly to BMMCs of BALB/c and C3H/HeJ mice. We have previously demonstrated that VacA susceptible cells expressed a VacA receptor (16), the receptor protein-tyrosine phosphatase β. Although we have not investigated in this study whether the direct binding of VacA to BMMCs was mediated by the same receptor, receptor protein-tyrosine phosphatase β, it is interesting to know that the activation of mast cells by VacA is mediated by this receptor.

           FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Direct binding of VacA to mast cells. VacA binding to BALB/c and C3H/HeJ BMMCs was investigated by flow cytometry using BMMCs alone (solid line) or with FITC-conjugate (dotted line), or with anti-VacA and FITC-conjugate (bold line). Nonspecific binding by FcγR on BMMCs was blocked by 2.4G2 (anti-FcγRII/III) Ab. Data shown were representatives of two independent experiments with similar results.

VacA induces cytokine production from BMMCs but not degranulation

Because activated mast cells have ability to produce various cytokines that play important roles in recruitment and activation of inflammatory cells, we next examined whether VacA enabled the stimulated mast cells to produce and secrete proinflammatory cytokines (19). As shown in Fig. 4⇓, BMMCs could respond to produce TNF-α, macrophage-inflammatory protein-1α, IL-1β, IL-6, IL-10, and IL-13 upon VacA stimulation in a dose-dependent manner. There were no significant differences in the production of cytokines from BMMCs of three strains of mice, BALB/c, C3H/HeN, and C3H/HeJ (p > 0.05), suggesting that unlike the responses of LPS from H. pylori (20), VacA-induced activation of mast cells was not mediated by Toll-like receptor 4. The viability of BMMCs at 3 or 6 h after stimulation with VacA was >98%, indicating cytokine release was not due to cytotoxic effect of VacA. The mucosal biopsy specimens from patients with H. pylori infection contain significantly elevated levels of TNF-α, IL-1β, IL-6, and IL-8 compared with those in specimens from uninfected individuals (21, 22, 23). However, it has been still unclear what products of bacteria do stimulate host cells or which cells produce these cytokines in response to bacterial products. Our results suggest that mast cell is the one candidate for producing cells of these cytokines upon VacA stimulation. Interestingly, the activation of mast cells did not lead to the infiltration of neutrophil in vivo (24 and 72 h after administration). We do not know the reason for that. VacA may not be a proper stimulant for mast cells to produce TNF-α, which is thought to be an important cytokine for recruitment of neutrophils (12), because the levels of TNF-α produced by mast cells upon VacA stimulation were not so high as those by other stimulant (13). Furthermore, VacA itself failed to trigger the release of β-hexosaminidase from BMMCs (data not shown). Because it has been reported that H. pylori or H. pylori extracts potentiate histamine release from rat serosal mast cells in vitro and can induce mast cell degranulation in vivo (24), molecules other than VacA in H. pylori extracts might have degranulating activity for mast cells.

           FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Cytokine production from mast cells upon VacA stimulation. BALB/c, C3H/HeN, and C3H/HeJ BMMCs were incubated with VacA at the concentrations as condition indicated in Material and Methods. The levels of cytokines in the supernatants were measured by ELISA. Data shown were mean ± SD of three independent experiments. Viability of the cells under each condition was >98%, as assessed by trypan blue dye exclusion test.

When we examined the effects of VacA on BMMCs after longer incubation, BMMCs were susceptible to VacA for vacuolization. After 8 h of incubation, BMMCs did not show vacuolization evaluated by measurement of neutral red uptake (OD value of control vs VacA (20 μg/ml): 0.084 ± 0.015 vs 0.083 ± 0.018, p > 0.05). The number of vacuolating mast cells significantly started to increase after 15 h of incubation (OD value of control vs VacA (20 μg/ml): 0.078 ± 0.017 vs 0.237 ± 0.032, p < 0.01), which might also explain the in vivo phenomenon that the infiltration of mast cells was prominent at 24 h but not at 72 h. After the accumulation of mast cells in the epithelium of gastric mucosa, they might die due to vacuolization.

In this study, we demonstrated that VacA, a toxin derived from H. pylori, could bind and directly activate mast cells for migration and production of proinflammatory cytokines. Although we still do not know what kinds of roles were played by these mast cells during H. pylori infection, it is possible that this might be a host early innate immune response to clear bacteria, and also this activation of mast cells by VacA may contribute to the pathogenesis of H. pylori-infected gastritis.

Acknowledgments

We thank Drs. A. Nakao, C. Nishiyama, and K. Maeda for helpful discussions, and Drs. Y. Kanamaru and T. Uchida for technical assistance.

Footnotes

  • ↵1 This work was supported in part by grants from the Ministry of Education, Science, and Culture, Japan. V.S. was supported by grants from Japan International Cooperation Agency.

  • ↵2 Address correspondence and reprint requests to Dr. Chisei Ra, Department of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University School of Medicine, Tokyo 173-8610, Japan. E-mail address: FceRICRA{at}med.nihon-u.ac.jp

  • ↵3 Abbreviations used in this paper: BMMC, bone marrow-derived mast cell; SCF, stem cell factor; MMC, mucosal mast cell.

  • Received October 24, 2001.
  • Accepted January 22, 2002.
  • Copyright © 2002 by The American Association of Immunologists

References

  1. ↵
    Blaser, M. J.. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. J. Gastroenterol. 102: 720
    OpenUrl
  2. ↵
    Cover, T. L., M. J. Blaser. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267: 10570
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Phadnis, S. H., D. Ilver, L. Janzon, S. Normark, T. U. Westblom. 1994. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect. Immun. 62: 155.7
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Salama, N. R., G. Otto, L. Tompkins, S. Falkow. 2001. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 69: 730
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Covacci, A., J. L. Telford, G. Del Giudice, J. Parsonnet, R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284: 1328
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Atherton, J. C., P. Cao, R. M. Peek, Jr, M. K. Tummuru, M. J. Blaser, T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific VacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270: 17771
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Telford, J. L., P. Ghiara, M. Dell‘Orco, M. Comanducci, D. Burroni, M. Bugnoli, M. F. Tecce, S. Censini. A. Covacci, Z. Xiang, et al 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179: 1653
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Ghiara. P., M., M. J. Marchetti, M. K. Blaser, T. L. Tummuru, E. D. Cover, L. S. Segal, L. S. Tompkins, R. Rappuoli. 1995. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun. 63: 4154
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Nakajima, S., B. Krishnan, H. Ota, A. M. Segura, T. Hattori, D. Y. Graham, R. M. Genta. 1997. Mast cell involvement in gastritis with or without Helicobacter pylori infection. J. Gastroenterol. 113: 746
    OpenUrlCrossRef
  10. ↵
    Van Doorn, N. E., E. P. Van Rees, F. Namavar, P. Ghiara, C. M. Vandenbroucke-Grauls, J. de Graaff. 1999. The inflammatory response in CD1 mice shortly after infection with a CagA+/VacA+ Helicobacter pylori strain. Clin. Exp. Immunol. 115: 421
    OpenUrlCrossRefPubMed
  11. ↵
    Kurose, I., D. N. Granger, D. J. Evans, Jr, D. G. Evans, D. Y. Graham, M. Miyasaka, D. C. Anderson, R. E. Wolf, G. Cepinskas, P. R. Kvietys. 1994. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. J. Gastroenterol. 107: 70
    OpenUrl
  12. ↵
    Malaviya, R., T. Ikeda, E. Ross, S. N. Abraham. 1996. Mast cell modulation of neutrophil recruitment and bacterial clearance at sites of infection through TNF-α. Nature 381: 77
    OpenUrlCrossRefPubMed
  13. ↵
    Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, H. Ogawa. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167: 2250
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Yahiro, K., T. Niidome, T. Hatakeyama, H. Aoyagi, H. Kurazono, P. I. Padilla, A. Wada, T. Hirayama. 1997. Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS. Biochem. Biophys. Res. Commun. 238: 629
    OpenUrlCrossRefPubMed
  15. ↵
    Cover, T. L., P. Cao, C. D. Lind, K. T. Tham, M. J. Blaser. 1993. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect. Immun. 61: 5008
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Yahiro, K., T. Niidome, K. Miyuki, T. Hatakeyama, H. Aoyagi, H. Kurazono, K. Imagawa, A. Wada, J. Moss, T. Hirayama. 1999. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase β. J. Biol. Chem. 274: 36693
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Taub, D., J. Dastych, N. Inamura, J. Upton, D. Kelvin, D. Metcalfe, J. Oppenhaeim. 1995. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J. Immunol. 154: 2393
    OpenUrlAbstract
  18. ↵
    Marchetti, M., B. Arico, D. Burroni, N. Figura, R. Rappuoli, P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267: 1655
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jauaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, M. E. Dorf. 1989. Interleukin-3 dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170: 245
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Kawahara, T., S. Eshima, A. Oka, T. Sugiyama, K. Kishi, K. Rokutan. 2001. Type I Helicobacter pylori lipopolysaccharide stimulated Toll-like receptor 4 and activated mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69: 4382
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Crabtree, J. E., T. M. Shallcross, R. V. Heatley, J. I. Wyatt. 1991. Mucosal tumor necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Gionchetti, P., D. Vaira, M. Campieri, J. Holton, M. Menegatti, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola, M. Miglioli, L. Barbara. 1994. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 89: 883
    OpenUrlPubMed
  23. ↵
    Gionchetti, P., D. Vaira, M. Campieri, J. Holton, M. Menegatti, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola, M. Miglioli, L. Barbara. 1994. Enhanced mucosal interleukin 6 and 8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 89: 883
    OpenUrlPubMed
  24. ↵
    Yamamoto, J., S. Watanabe, M. Hirose, T. Osada, C. Ra, N. Sato. 1990. Roles of mast cells as a trigger of inflammation in Helicobacter pylori infection. J. Physiol. Pharmacol. 50: 17
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Immunology: 168 (6)
The Journal of Immunology
Vol. 168, Issue 6
15 Mar 2002
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines
Volaluck Supajatura, Hiroko Ushio, Akihiro Wada, Kinnosuke Yahiro, Ko Okumura, Hideoki Ogawa, Toshiya Hirayama, Chisei Ra
The Journal of Immunology March 15, 2002, 168 (6) 2603-2607; DOI: 10.4049/jimmunol.168.6.2603

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines
Volaluck Supajatura, Hiroko Ushio, Akihiro Wada, Kinnosuke Yahiro, Ko Okumura, Hideoki Ogawa, Toshiya Hirayama, Chisei Ra
The Journal of Immunology March 15, 2002, 168 (6) 2603-2607; DOI: 10.4049/jimmunol.168.6.2603
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients
  • Cutting Edge: Promoting T Cell Factor 1+ T Cell Self-Renewal to Improve Programmed Cell Death Protein 1 Blockade
  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606